Robert Stoehr

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants.

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants.

Journal: International journal of molecular sciences

Published: September 22, 2018

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab.

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 18, 2018

Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.

Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.

Journal: International journal of molecular sciences

Published: July 30, 2018

No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis.

No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: July 01, 2018

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.

Journal: Translational oncology

Published: December 12, 2016

Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer.

Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer.

Journal: American journal of clinical pathology

Published: October 17, 2014

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.

Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.

Journal: BMC cancer

Published: October 09, 2013

Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients.

Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients.

Journal: The Journal of pathology

Published: April 16, 2013

Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.

Mdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.

Journal: British journal of cancer

Published: June 26, 2008

Showing 1-9 of 9

Last Updated: 09/26/2026